Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
2 openings available.
Employer will assist with relocation costs.
To achieve a thorough understanding of marketing and commercial strategies within the Rare Diseases Franchise. This unique program will be in support of Global commercial and brand strategy development during the first year, followed by tactical implementation and execution of these strategies in the United States during the second year. The Fellow will work in several key functional areas within the commercial organization. Upon completion of this program, Fellows will gain an understanding of competitive dynamics and customer needs. In addition, they will be well versed in product positioning and resonant marketing content generation. The experience will enable Fellows to embark on a career within the pharmaceutical industry in product management, commercialization, and market development.
Assist the cross-functional core team in the development of Global and US brand strategy and support its implementation.
Collaborate on the development and refinement of product value messaging and disease-awareness materials to support strategic priorities globally and regionally.
Increase brand and disease state awareness through coordinated marketing opportunities at conferences.
Lead and execute orphan disease awareness and product marketing campaigns targeted at HCPs and patients.
Assist in the design and development of digital and omnichannel strategies to secure an effective level of interaction with HCPs and patients
Manage agency partners to produce strategic materials on schedule and within budget.
Identify data gaps and develop appropriate solutions via the coordination of market research activities.
Compile and disseminate competitive intelligence insights across the global, regional, and country brand teams.
Provide commercial assessments regarding business development opportunities that may complement the Rare Diseases portfolio.
Gain insight into the integral and strategic roles of various functions within the Rare Diseases Business Unit throughout the lifecycle of a product.
To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.
The MCPHS application portal will open up on October 2, 2023. Applicants must upload the following application materials to the online portal by November 17, 2023:
§Letter of intent
§Unofficial college transcript
§Contact information for three references. References will receive an electronic recommendation form to complete separately.
Incomplete applications WILL NOT be reviewed. Interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendation evaluation forms must be submitted no later than November 27, 2023, via the online portal. This is NOT a letter of recommendation but an online form that the reference will need to complete.
Rolling Application Review & Interviews
All submitted applications will be reviewed on a rolling basis. Interviews will also be offered on a rolling basis and opportunities are limited. Priority will be given to those applicants who apply early, well in advance of the deadline.
Rolling interviews will begin mid-October with pre-screens and a mixture of interview rounds, and will conclude in December at the end of the ASHP Midyear Clinical Meeting. Candidates will be notified if selected for an interview.
ASHP Midyear & Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Burbank, CA. Applicants are strongly encouraged to attend. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the sponsoring company’s location pending COVID – 19 restrictions.
Recognizing that the choice of a Post-Doctoral Industry Fellowship is an important decision, MCPHS in conjunction with the Academic Industry Fellowship Alliance (AIFA), has agreed to extend offers for Fellowships no earlier than December 13, 2023.
Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
§Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Sanofi’s global specialty care business unit focuses on rare diseases, rare blood disorders, neurology, immunology, and oncology. Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Our cutting-edge science and manufacturing, fueled by data and digital technologies, have the potential to transform the practice of medicine for millions of people around the world.